BioCryst Pharmaceuticals
BCRX
#4791
Rank
โ‚น131.08 B
Marketcap
โ‚น632.85
Share price
2.60%
Change (1 day)
48.88%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น81.09 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น81.09 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น80.95 B15.84%
2022-12-31โ‚น69.89 B35.08%
2021-12-31โ‚น51.73 B99.86%
2020-12-31โ‚น25.88 B164.92%
2019-12-31โ‚น9.77 B43.18%
2018-12-31โ‚น6.82 B13.12%
2017-12-31โ‚น6.03 B0.58%
2016-12-31โ‚น5.99 B20.94%
2015-12-31โ‚น4.95 B27.79%
2014-12-31โ‚น3.88 B25.67%
2013-12-31โ‚น3.08 B-2.57%
2012-12-31โ‚น3.16 B-11.1%
2011-12-31โ‚น3.56 B81.07%
2010-12-31โ‚น1.96 B-24.11%
2009-12-31โ‚น2.59 B41.09%
2008-12-31โ‚น1.83 B-39.77%
2007-12-31โ‚น3.05 B45.67%
2006-12-31โ‚น2.09 B14.15%
2005-12-31โ‚น1.83 B1252.82%
2004-12-31โ‚น0.13 B80.86%
2003-12-31โ‚น75.05 M33.54%
2002-12-31โ‚น56.2 M-48.97%
2001-12-31โ‚น0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น73.97 B-8.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น200.99 B 147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.11 B-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น190.13 B 134.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.989 T 3,586.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.14 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.042 T 6,118.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น95.23 B 17.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.31 B-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA